For both patients and their healthcare providers (HCPs), the requirement that prior authorizations (PAs) be obtained from health insurers for many branded and specialty medications continues to act as a significant roadblock, according to David Fidler, senior director product innovation at ConnectiveRx.
For years, you’ve been replacing your patient’s testosterone. Maybe it’s time to consider replacing how it’s delivered. While there have been frequent, and prominent, new products developed for treating hypogonadism in the last 20 years, one particular type of option has been scarce – and it may be the one that patients want and/or prefer. […]
EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, partnered with WorldQuant Predictive (WQP), a market leader in quantitative predictions and data-driven decisions through a cloud-based artificial intelligence (AI) platform, to improve the end result for patients.
AiCure’s phone app helps clinical trials keep tabs on which participants have taken their medications correctly and which have not.
EVERSAN and Havas Health & You announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.
Innovations in diabetes care go beyond new therapeutic classes. Pharmaceutical companies are continuing to invest in new technology to help improve diabetes treatment and patient adherence with progress ranging from artificial pancreases to smart insulin pens and pumps.
We now have technology to help us keep track of mundane – but crucial – tasks. From wearables to smartphones, we have unlimited opportunities to make technology work for us.
MedBridge, a developer of patient engagement and clinical education software, has launched MedBridge GO – a patient-facing mobile app designed to improve adherence to clinician-assigned home exercise programs (HEP).
Introducing mobile into the patient engagement journey is one way that brands can drive efficiencies across three key areas.
Understand the meaning and implications of polypharmacy and the issues it causes for patient adherence; Discover policies, technologies and procedures that can eliminate or reduce the effects of polypharmacy ensuring quality outcomes; Highlight issues Pharmacist Partners, as an organization, has remedied and the technology they utilize to decrease overuse or underuse of medication